Market Cap
$126.4M
NR
NRXPW
NRX Pharmaceuticals, Inc.
—
Market cap$126.4M
High Impact Filing (8/10) Biotech & Drug Discovery
Snapshot
The big-picture read on NRXPW right now — valuation, ownership and activity at a glance.
Cap Size
Micro Cap
Inst. Holders
2 funds
Inst. Value
$347.00
Inst. Activity
0 buys / 1 sells
SEC Reports
4
Price chart 30d -15.3%
Daily candles (open–high–low–close) with volume. Green = up day, red = down day.
No data for this timeframe.
Vol
Recent activity
The latest filings, insider trades, analyst actions, press and options flow — newest first.
Jun 4, 2026 SEC Jun 3, 2026 SEC Jun 2, 2026 SEC
NRx Pharmaceuticals closed a firm-commitment underwritten public offering of 5,714,286 shares of common stock at $3.50 p
8-K — Impact 6/10
NRx Pharmaceuticals is conducting a firm-commitment underwritten public offering of 5,714,286 shares of common stock at
424B5 — Impact 6/10
NRx Pharmaceuticals filed a preliminary prospectus supplement for an underwritten firm-commitment common stock offering
424B5 — Impact 6/10
Mar 31, 2026 Inst.
UBS Group AG — NEAR_EXIT
13 shares (—)
Dec 31, 2025 Inst.
UBS Group AG — DOUBLED
1,852 shares ($131.00)
Reports & filings
AI-scored summaries of recent SEC filings and press releases, with sentiment and impact.
4 SEC filing reports analyzed · 0 bullish, 4 bearish, 0 mixed, 0 neutral · avg impact 6.5/10.
BEARISH8-K6/10
NRx Pharmaceuticals closed a firm-commitment underwritten public offering of 5,714,286 shares of com
Jun 4, 2026
BEARISH424B56/10
NRx Pharmaceuticals is conducting a firm-commitment underwritten public offering of 5,714,286 shares
Jun 3, 2026
BEARISH424B56/10
NRx Pharmaceuticals filed a preliminary prospectus supplement for an underwritten firm-commitment co
Jun 2, 2026
BEARISH25-NSE8/10
Nasdaq filed a Form 25-NSE to remove from listing and deregister the warrants (NRXPW) of NRX Pharmac
May 22, 2026
Earnings estimates
Forecast earnings per share and revenue by period — and whether estimates are rising.
| Period | EPS Est. | Range | Growth | 30d Rev | Up/Dn | Revenue | # |
|---|---|---|---|---|---|---|---|
| Current Q | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Next Q | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Current FY | $0.00 | $0.00–$0.00 | — | — | — | $0.0B | — |
| Next FY | $0.00 | $0.00–$0.00 | — | — | — | $0.3B | — |
Institutional ownership
Which big funds own NRXPW (from quarterly 13F filings) and who is adding or trimming.
2 institutional holders with $347.00 total value (23,606 shares) as of 2026-Q1. Top holders: UBS, WOLVERINE. Net selling activity: 1 institutions trimmed/exited vs 0 added.
Top holders — 2026-Q1
| Fund | Shares | Value | % Tracked | Last move |
|---|---|---|---|---|
| UBS Group AG | 13 | $0.00 | 0.0% | NEAR_EXIT -99.3% |
| WOLVERINE ASSET MANAGEMENT LLC | 23,593 | $347.00 | 100.0% | DOUBLED +290.7% |
Recent position changes
| Fund | Action | Prev | Current | Change | Value |
|---|---|---|---|---|---|
| UBS Group AG | NEAR_EXIT | 1,852 | 13 | -99.3% | — |
| UBS Group AG | DOUBLED | 18 | 1,852 | +10188.9% | $131.00 |
| UBS Group AG | NEAR_EXIT | 1,500 | 18 | -98.8% | $1.00 |
| UBS Group AG | ADD | 1,032 | 1,500 | +45.3% | $128.00 |
| WOLVERINE ASSET MANAGEMENT LLC | DOUBLED | 5,190 | 20,278 | +290.7% | $1.4K |
| UBS Group AG | TRIM | 3,911 | 1,032 | -73.6% | $73.00 |
| WOLVERINE ASSET MANAGEMENT LLC | TRIM | 15,392 | 5,190 | -66.3% | $664.00 |
| UBS Group AG | TRIM | 15,251 | 3,911 | -74.4% | $501.00 |
Short interest & halts
FINRA semi-monthly short positions, Reg SHO threshold status, and recent trading halts for NRXPW.
Shares short
5,154
Settlement May 15, 2026
Change vs prior
-83.1%
Semi-monthly cycle
Days to cover
1.0
At avg daily volume
All NRXPW filing & press-release reports (4)
- 8-K reportJun 4, 2026
- 424B5 reportJun 3, 2026
- 424B5 reportJun 2, 2026
- 25-NSE reportMay 22, 2026